A Phase 4 interventional study of Oral Tablet in Postpartum Preeclampsia, sponsored by Hossam Ahmed Abd Ellah. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2018-04-04.
Sponsored by Hossam Ahmed Abd Ellah · Phase 4, Interventional, and Treatment
Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy research has focused on the antenatal complications' for both mother and baby and the risks and benefits of administering antihypertensive therapy prior to delivery hypertension disorders of pregnancy often persist following delivery and sometimes arise de novo postpartum one of the maternal complications of pre eclampsia is residual chronic hypertension in about 1/3 of cases elevated blood pressure is seen in 6%to 8% of all pregnancies hypertension (arterial pressure >140/90 mmhg) in pregnancy is classified into one of four conditions
Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy research has focused on the antenatal complications' for both mother and baby and the risks and benefits of administering antihypertensive therapy prior to delivery hypertension disorders of pregnancy often persist following delivery and sometimes arise de novo postpartum one of the maternal complications of pre eclampsia is residual chronic hypertension in about 1/3 of cases elevated blood pressure is seen in 6%to 8% of all pregnancies hypertension (arterial pressure >140/90 mmhg) in pregnancy is classified into one of four conditions
Exclusion Criteria:
Women with history of secondary hypertension Women with eclampsia who need intensive care unit admission and indicated other drugs rather than oral nifedipine and oral labetalol Women who have any contraindication to Nifedipine or labetalol
Women who take the oral tablets of nifedipine till discharge of hospital
Drug: Oral Tablet
Women who take the oral tablets of labetalol till discharge of hospital
Drug: Oral Tablet
oral labetalol tablets and oral nifedipine tablets
Also known as: Monitoring blood pressure
control blood pressure
duration,total dose to achieve blood pressure below the critical value between 140 and 150 mmHg systolic and 90-100 mmHg diastolic by monitoring of blood pressure
Time frame: till discharge of hospital about two days
Resolution of complications
Measured by monitoring of blood pressure and monitoring of the complications
Time frame: till discharge of hospital about two days
Improvement of hematological values
By repeated Complete blood count
Time frame: till discharge of hospital about two days
Side effects in both groups
Monitoring if there is any side effect of any drug
Time frame: till discharge of hospital about two days
Improvement of other investigations
Monitoring by repeated urine analysis,other investigations
Time frame: till discharge of hospital about two days
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.